factor-a are well known as angiogenic factors.
Recently, vascular endothelial growth factor (VEGF) has been studied as an angiogenic factor (Keck et al, 1989; Leung et al, 1989) . VEGF was discovered because of its ability to increase the permeability of the microvasculature to circulating macromolecules (Senger et al, 1983) . VEGF is an endothelial cellspecific antigen and angiogenic factor in vivo, and this factor plays an important role in neovascularization of various kinds of neoplasms. The overexpression of VEGF has been demonstrated in neoplasms of the colon (Brown et al, 1993; Takahashi et al, 1995) , breast , brain (Berkman et al, 1993) , ovary (Boocock et al, 1995) , and liver (Suzuki et al, 1996) compared with normal tissue (Berse et al, 1992) .
Four different isoforms of VEGF transcripts encoding polypeptides of 206, 189, 165 and 121 amino acids have been reported to be expressed in human cells (Houck et al, 1991) , and these VEGF isoforms possess different biological activities (Houck et al, 1992; Park et al, 1993) . VEGF121 and VEGF165 are secreted in soluble form, whereas the two larger isoforms (VEGF189 and VEGF206) remain associated with cells because of their stronger affinities for cell-surface proteoglycans. VEGF121 is not a heparin-binding protein, while the other isoforms possess heparinbinding activity . The mitogenic activities of VEGF121 and VEGF165 are inhibited by platelet factor-4 (Gengrinovitch et al, 1995) .
VEGF165 is expressed in most tissues , but the precise expression patterns of other VEGF transcript isoforms are not well understood. Alternative expression of isoforms of VEGF mRNA is regulated by cell density in colon cancer cell lines (Koura et al, 1996) . The patterns of expression of VEGF mRNA isoforms are not different between tumour and non-tumour tissues in the liver (Suzuki et al, 1996) . The clinicopathological significance of the different patterns of expression of VEGF mRNA isoforms in colon cancer is not well understood. Thus, we analysed the correlation between VEGF isoform expression pattern and clinical features in colon cancers.
MATERIALS AND METHODS Subjects and tissue samples
The subjects in this study were 61 patients with colon cancer who underwent surgical resections between October, 1989 and October, 1991 , at Tokai University Hospital. All patients were evaluated by TNM score (UICC, 1978) . Patients' characteristics are summarized in Table 1 . Surgical specimens were rapidly frozen and stored at -80°C until analyses. Total cellular RNA was prepared from frozen specimens (Sambrook et al, 1989) .
VEGF mRNA isoform pattem in colon cancer 999 RT-PCR analysis to detect VEGF isoform transcripts
We evaluated isoforms of VEGF mRNA by RT-PCR using the following primers: V-S, 5-AAGCCATCCTGTGTGCCCCT-GATG-3; V-S4, 5-CGGATCAAACCTCACCAAGGCC-3; V-A, 5-GCGAATTCCTCCTGCCCGGCTCAC-3; V-A7, 5-CTTTCTC-CGCTCTGAGCAAGGC-3 ( Figure 1 Under conditions similar to those described above, TGF-P1
gene expression was also estimated by RT-PCR with the following primers:
TGF-P1I-S, 5-GCCCTGGACACCAACTATTGC-3 (1679-1699);
Activation of c-K-ras oncogene
Point mutations in the c-K-ras oncogene were evaluated by the enriched PCR method as reported previously (Ando et al, 1991 None of the tumours examined showed VEGF206 expression. These isoform patterns of VEGF mRNA were confirmed with two sets of amprimers to amplify different portions of the VEGF cDNA ( Figure 2 and Figure 3 ). Twenty-two of 25 normal colon tissues did not express VEGFmRNA. One of the three normal colon specimens expressing VEGF showed the type 1 isoform VEGF 121, while the other normal mucosal specimens showed type 3 isoform expression. 
Correlation between VEGF-mRNA isoform and clinical characteristics
Twelve patients presented with liver metastases at the time of operation, and four patients revealed liver metastases during the follow-up period. Only one patient presented with pulmonary metastasis at the time of the operation, whereas such metastases were detected in four patients during the follow-up period. Twenty-five patients died because of colon cancer during the follow-up period.
The 32 patients with colon cancers with the type 3 isoform expression pattern showed significantly poorer prognosis than the remaining 29 patients with type 1 and 2 transcript patterns (P < 0.01, Cox-Mantel, Figure 4 ).
The patients with colon cancers showing the type 3 isoform expression pattern had a significantly higher incidence (12 out of 32, 37.5%) of liver metastasis than those (4 out of 29, 13.8%) with type 1 and 2 isoform patterns (P < 0.05, X2 test, Table 1 Activation of c-K-ras oncogene Activation of the c-K-ras oncogene was detected in 27 of the 61 colon cancers examined. Eighteen of these 27 (67%) colon cancers revealed point mutation (GGT -* GAT) at codon 12 of the c-K-ras gene. No homozygous point mutations were detected. Activation of the c-K-ras oncogene was not correlated with the VEGF mRNA isoform pattern.
DISCUSSION
Many studies have focused on angiogenesis with regard to distant metastasis of colon cancers. Vascular endothelial growth factor (VEGF) has been studied as an angiogenic factor (Keck et al, 1989; Leung et al, 1989) . We detected VEGF transcripts in all the primary human colon cancer specimens, while VEGF expression was detectable in 3 of 25 normal colon tissues by RT-PCR. The colon cancers generally overexpressed the VEGF gene, whereas VEGF transcripts were faint in the normal colonic specimens on Northern blots. A higher incidence of cells expressing VEGF was reported in gastrointestinal cancer than in the normal mucosa (Brown et al, 1993) . The overexpression of VEGF was also demonstrated in colon cancers compared with the levels in the normal colonic mucosa (Takahashi et al, 1995) . Our results support VEGF overexpression in colon cancers.
It is possible that variable amounts of stromal RNA were copurified from the tumours in these bulk studies. We established several colon cancer xenografts of which stromal elements were replaced by murine tissue and stored the corresponding primary colon cancer materials. (Suzuki et al, 1996) . All neoplasms of the central nervous system also express VEGF121, VEGF165 and VEGF189 (Berkman et al, 1993) . A colon cancer cell line expressed these three isoforms of VEGF mRNA in vitro (Koura et al, 1996) . However, it is not clear what proportion of colon cancers express these isoforms. The results of this study show that fewer colon cancers express these aberrant isoforms of VEGF than brain tumours or hepatocellular carcinomas. We did not observe the expression of VEGF206, which was detected in a human fetal liver cDNA library (Houck et al, 1991) , in any of our specimens.
It is not known which factors affect the isoforms of VEGF mRNA in colon cancers, although all colon cancers showed overexpression of the VEGF gene compared with normal tissues. In this study, the VEGF mRNA isoform pattern was not significantly correlated with the gene expression level. Activation of the c-K/Hras oncogenes is correlated with VEGF gene overexpression in rat intestinal cell lines (Rak et al, 1995) . We thus examined activation of the K-ras oncogene in colon cancers. Forty-five percent of the colon cancers showed activation of the K-ras oncogene, while there was no correlation between ras oncogene activation and VEGF isoform pattern. Expression of the VEGF receptor KDR is correlated with hepatic metastasis in colon cancer (Takahashi et al, 1995) . We also examined the expression of the VEGF receptor (flt-1, KDR) gene, but found no correlation with the VEGF isoform pattern. Transforming growth factor-p (TGF-[B) was reported to up-regulate VEGF gene expression (Dolecki et al, 1991 ), but we found no correlation between TGF, production and VEGF mRNA isoforms in colon cancer.
Little is known about the angiogenic properties of the four different isoforms of VEGF. Among the various isoforms VEGF189 protein has the strongest binding capacity to extracellular matrix (ECM) components. Endothelial cells cultured on ECM derived from cells expressing VEGF189 showed markedly stimulated proliferation (Houck et al, 1992; Park et al, 1993) . The VEGF189 isoform was up-regulated specifically in confluent cultures of a colon cancer cell line in vitro (Koura et al, 1996) , and it was suggested that this up-regulation of VEGF189 might result in increased angiogenesis, tumour growth and metastasis. It has been suggested that the overexpression of VEGF is associated with vascularity of colon cancer (Takahashi et al, 1995) . However, there were no reports of a clear correlation between VEGF isoform expression pattern and clinical characteristics of colon cancer. We showed that the type 3 isoform pattern expression (VEGF189) was significantly correlated with venous involvement in colon cancer. In this study, we also demonstrated that the aberrant expression of the VEGF189 isoform was correlated with liver metastasis and Ml stage in colon cancer.
Recent studies have indicated a correlation between up-regulation of total VEGF and hepatic metastasis in colon cancer (Warren et al, 1995) . However, the results presented here suggest that it is important to examine not only the level of VEGF expression but British Journal of Cancer (1998) 77(6), 998-1002 * a * -0
Cancer Research Campaign 1998 also those isoforms that are expressed to discuss prognostic or malignant features of colon cancer. Examination of the VEGF mRNA isoform patterns will be helpful in predicting the prognosis of patients with colon cancer. ABBREVIATIONS VEGF, vascular endothelial growth factor; RT-PCR, reverse transcription polymerase chain reaction
